Observational × Ovarian Neoplasms × Genitourinary × Clear all Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
Recruiting
1,100 enrolled
National Cancer Institute "Cancer Moonshot Biobank"
Active not recruiting
1,600 enrolled
TraveraRTGx
Completed
72 enrolled
ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors
Completed
140 enrolled
DP-04
Recruiting
100 enrolled
(CLOCS-2)
Recruiting
2,900 enrolled
BASECAMP-1
Recruiting
200 enrolled
Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study
Completed
64 enrolled
iCaRe2
Recruiting
999,999 enrolled
CAMPERR
Recruiting
7,000 enrolled
SCORE
Recruiting
9,600 enrolled
Ascertainment of Peripheral Blood or Saliva Samples for Genetic Epidemiology Studies of Familial Cancers
Active not recruiting
992 enrolled
CCANED-CIPHER
Recruiting
6,000 enrolled
Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes
Completed
22 enrolled
Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer Survivors
Recruiting
250 enrolled
LIBERATE
Recruiting
2,500 enrolled
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Recruiting
50,000 enrolled
Drug Intensive Monitoring Study of Olaparib in Clinical Practice Among Chinese Patients
Completed
1,018 enrolled
Evaluating an Alternative Clinical Genetics Cancer Care Delivery Model: A Pilot Study of Patient Outcomes
Active not recruiting
1,047 enrolled
OLAP
Completed
661 enrolled
DESCENT-1
Enrolling by invitation
400 enrolled
PRIORITY
Completed
346 enrolled 9 charts
Tempus Priority Study: A Pan-tumor Observational Study
Active not recruiting
1,000 enrolled
LONGEVITI
Recruiting
75 enrolled
Tissue Oximetry's Measurement in Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy
Recruiting
50 enrolled
PREFER
Completed
1,429 enrolled
INSPIRE
Recruiting
5,350 enrolled
MOHCCN-O
Recruiting
500 enrolled
ROOT
Completed
167 enrolled
Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs
Withdrawn
Development and Validation of a Prediction Model for AKI Following Cisplatin-Based HIPEC in Patients With Ovarian Cancer
Completed
150 enrolled
QUANTUM
Enrolling by invitation
3,000 enrolled
AURA
Completed
13 enrolled
RADIANT
Completed
16 enrolled
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions
Completed
17,667 enrolled
CER
Recruiting
15,000 enrolled
Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis
Unknown
2,700 enrolled
Investigating the Diagnostic Potential of Tear Proteins in Cancer - A Pilot Study
Unknown
500 enrolled
Follow-up Protocol for Patients With Cancer/AIDS/Skin Disease
Completed
1,031 enrolled
CADENCE
Unknown
15,000 enrolled
Clinical Study of Pan-cancer DNA Methylation Test in Plasma
Unknown
3,000 enrolled
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors
Completed
5,133 enrolled
WiZen
Completed
670,000 enrolled
DETECT
Completed
458 enrolled
PASSION
Unknown
1,800 enrolled
SPACE2
Unknown
150 enrolled
ADOPT
Completed
18 enrolled
Continuation of Follow-up of DES-Exposed Cohorts
Completed
10,805 enrolled
Study to Evaluate the Safety of Nanoxel M Inj.
Unknown
1,498 enrolled
T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant
Terminated
150 enrolled